APP and Alzheimer disease: More than two decades of experimental research and post-mortem studies have identified several pathogenic mechanisms in the AD brain such as the accumulation of amyloid beta peptide (predominantly Aβ 42 and Aβ 40) and phosphorylated tau protein, oxidative damage to specific proteins or in general to lipid, protein and DNA, mitochondrial dysfunction and inflammatory response [4-11].